beanibazar cancer and general hospital
beanibazar cancer and general hospital Company Information
Company Number
06882020
Next Accounts
Dec 2025
Shareholders
-
Group Structure
View All
Industry
Hospital activities
Registered Address
74-76 tower bridge road, london, SE1 4TP
Website
bbchospital.orgbeanibazar cancer and general hospital Estimated Valuation
Pomanda estimates the enterprise value of BEANIBAZAR CANCER AND GENERAL HOSPITAL at £158.9k based on a Turnover of £298.6k and 0.53x industry multiple (adjusted for size and gross margin).
beanibazar cancer and general hospital Estimated Valuation
Pomanda estimates the enterprise value of BEANIBAZAR CANCER AND GENERAL HOSPITAL at £0 based on an EBITDA of £-33.3k and a 3.68x industry multiple (adjusted for size and gross margin).
beanibazar cancer and general hospital Estimated Valuation
Pomanda estimates the enterprise value of BEANIBAZAR CANCER AND GENERAL HOSPITAL at £3.3m based on Net Assets of £1.3m and 2.53x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Beanibazar Cancer And General Hospital Overview
Beanibazar Cancer And General Hospital is a live company located in london, SE1 4TP with a Companies House number of 06882020. It operates in the hospital activities sector, SIC Code 86101. Founded in April 2009, it's largest shareholder is unknown. Beanibazar Cancer And General Hospital is a established, micro sized company, Pomanda has estimated its turnover at £298.6k with healthy growth in recent years.
Upgrade for unlimited company reports & a free credit check
Beanibazar Cancer And General Hospital Health Check
Pomanda's financial health check has awarded Beanibazar Cancer And General Hospital a 4.5 rating. We use a traffic light system to show it exceeds the industry average on 4 measures and has 3 areas for improvement. Company Health Check FAQs
4 Strong
3 Regular
3 Weak
Size
annual sales of £298.6k, make it smaller than the average company (£4.7m)
£298.6k - Beanibazar Cancer And General Hospital
£4.7m - Industry AVG
Growth
3 year (CAGR) sales growth of 15%, show it is growing at a faster rate (8.1%)
15% - Beanibazar Cancer And General Hospital
8.1% - Industry AVG
Production
with a gross margin of 34.4%, this company has a comparable cost of product (34.4%)
34.4% - Beanibazar Cancer And General Hospital
34.4% - Industry AVG
Profitability
an operating margin of -16.4% make it less profitable than the average company (9.9%)
-16.4% - Beanibazar Cancer And General Hospital
9.9% - Industry AVG
Employees
with 4 employees, this is below the industry average (57)
- Beanibazar Cancer And General Hospital
57 - Industry AVG
Pay Structure
on an average salary of £33.7k, the company has an equivalent pay structure (£33.7k)
- Beanibazar Cancer And General Hospital
£33.7k - Industry AVG
Efficiency
resulting in sales per employee of £74.6k, this is equally as efficient (£75.7k)
- Beanibazar Cancer And General Hospital
£75.7k - Industry AVG
Debtor Days
it gets paid by customers after 1 days, this is earlier than average (21 days)
1 days - Beanibazar Cancer And General Hospital
21 days - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- - Beanibazar Cancer And General Hospital
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Beanibazar Cancer And General Hospital
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 7394 weeks, this is more cash available to meet short term requirements (42 weeks)
7394 weeks - Beanibazar Cancer And General Hospital
42 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 0.4%, this is a lower level of debt than the average (41.6%)
0.4% - Beanibazar Cancer And General Hospital
41.6% - Industry AVG
BEANIBAZAR CANCER AND GENERAL HOSPITAL financials
Beanibazar Cancer And General Hospital's latest turnover from March 2024 is £298.6 thousand and the company has net assets of £1.3 million. According to their latest financial statements, we estimate that Beanibazar Cancer And General Hospital has 4 employees and maintains cash reserves of £745.1 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Apr 2012 | Apr 2011 | Apr 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 298,596 | 225,315 | 367,632 | 198,594 | 228,546 | 357,690 | 35,511 | 49,690 | 60,361 | ||||||
| Other Income Or Grants | |||||||||||||||
| Cost Of Sales | |||||||||||||||
| Gross Profit | |||||||||||||||
| Admin Expenses | |||||||||||||||
| Operating Profit | |||||||||||||||
| Interest Payable | 172 | 47 | 26 | ||||||||||||
| Interest Receivable | |||||||||||||||
| Pre-Tax Profit | -8,817 | -18,817 | 147,425 | 3,806 | 1,649 | 312,611 | 20,416 | 40,673 | 49,808 | ||||||
| Tax | |||||||||||||||
| Profit After Tax | -8,817 | -18,817 | 147,425 | 3,806 | 1,649 | 312,611 | 20,416 | 40,673 | 49,808 | ||||||
| Dividends Paid | |||||||||||||||
| Retained Profit | -8,817 | -18,817 | 147,425 | 3,806 | 1,649 | 312,611 | 20,416 | 40,673 | 49,808 | ||||||
| Employee Costs | |||||||||||||||
| Number Of Employees | |||||||||||||||
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Apr 2012 | Apr 2011 | Apr 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 555,943 | 533,684 | 543,629 | 556,062 | 570,888 | 526,027 | 544,281 | 543,396 | 545,350 | 460,199 | 205,414 | 162,854 | 103,607 | 43,934 | |
| Intangible Assets | |||||||||||||||
| Investments & Other | |||||||||||||||
| Debtors (Due After 1 year) | |||||||||||||||
| Total Fixed Assets | 555,943 | 533,684 | 543,629 | 556,062 | 570,888 | 526,027 | 544,281 | 543,396 | 545,350 | 460,199 | 205,414 | 162,854 | 103,607 | 43,934 | |
| Stock & work in progress | |||||||||||||||
| Trade Debtors | 1,238 | 648,925 | 569,694 | 1,339 | 16,928 | 13,651 | 13,636 | ||||||||
| Group Debtors | |||||||||||||||
| Misc Debtors | 25,095 | ||||||||||||||
| Cash | 745,136 | 779,818 | 788,092 | 630,999 | 610,172 | 593,652 | 456,970 | 430,758 | 559,457 | 236,390 | 7,529 | 46,788 | 50,048 | ||
| misc current assets | 2,088 | ||||||||||||||
| total current assets | 746,374 | 779,818 | 788,092 | 630,999 | 610,172 | 648,925 | 571,782 | 594,991 | 473,898 | 444,409 | 573,093 | 261,485 | 7,529 | 46,788 | 50,048 |
| total assets | 1,302,317 | 1,313,502 | 1,331,721 | 1,187,061 | 1,181,060 | 1,174,952 | 1,116,063 | 1,138,387 | 1,019,248 | 904,608 | 778,507 | 424,339 | 111,136 | 90,722 | 50,048 |
| Bank overdraft | |||||||||||||||
| Bank loan | |||||||||||||||
| Trade Creditors | 1,740 | 1,593 | 6,448 | 3,902 | 3,121 | 3,194 | 3,205 | 1,119 | 1,118 | 1,439 | |||||
| Group/Directors Accounts | |||||||||||||||
| other short term finances | |||||||||||||||
| hp & lease commitments | |||||||||||||||
| other current liabilities | 5,240 | 5,868 | 5,417 | 3,327 | 3,678 | 831 | 239 | 241 | 240 | ||||||
| total current liabilities | 5,240 | 7,608 | 7,010 | 9,775 | 7,580 | 3,121 | 3,194 | 3,205 | 1,119 | 1,118 | 1,439 | 831 | 239 | 241 | 240 |
| loans | |||||||||||||||
| hp & lease commitments | |||||||||||||||
| Accruals and Deferred Income | |||||||||||||||
| other liabilities | |||||||||||||||
| provisions | |||||||||||||||
| total long term liabilities | |||||||||||||||
| total liabilities | 5,240 | 7,608 | 7,010 | 9,775 | 7,580 | 3,121 | 3,194 | 3,205 | 1,119 | 1,118 | 1,439 | 831 | 239 | 241 | 240 |
| net assets | 1,297,077 | 1,305,894 | 1,324,711 | 1,177,286 | 1,173,480 | 1,171,831 | 1,112,869 | 1,135,182 | 1,018,129 | 903,490 | 777,068 | 423,508 | 110,897 | 90,481 | 49,808 |
| total shareholders funds | 1,297,077 | 1,305,894 | 1,324,711 | 1,177,286 | 1,173,480 | 1,171,831 | 1,112,869 | 1,135,182 | 1,018,129 | 903,490 | 777,068 | 423,508 | 110,897 | 90,481 | 49,808 |
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Apr 2012 | Apr 2011 | Apr 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||
| Operating Profit | |||||||||||||||
| Depreciation | 15,510 | 9,945 | 12,433 | 15,540 | 19,247 | 25,245 | 25,555 | 7,714 | 1,104 | ||||||
| Amortisation | |||||||||||||||
| Tax | |||||||||||||||
| Stock | |||||||||||||||
| Debtors | 1,238 | -648,925 | 79,231 | 568,355 | -15,589 | 3,277 | 15 | -11,459 | 25,095 | ||||||
| Creditors | -1,740 | 147 | -4,855 | 2,546 | 781 | -73 | -11 | 2,086 | 1 | -321 | 1,439 | ||||
| Accruals and Deferred Income | -628 | 451 | 2,090 | -351 | 3,678 | -831 | 592 | -2 | 1 | 240 | |||||
| Deferred Taxes & Provisions | |||||||||||||||
| Cash flow from operations | |||||||||||||||
| Investing Activities | |||||||||||||||
| capital expenditure | |||||||||||||||
| Change in Investments | |||||||||||||||
| cash flow from investments | |||||||||||||||
| Financing Activities | |||||||||||||||
| Bank loans | |||||||||||||||
| Group/Directors Accounts | |||||||||||||||
| Other Short Term Loans | |||||||||||||||
| Long term loans | |||||||||||||||
| Hire Purchase and Lease Commitments | |||||||||||||||
| other long term liabilities | |||||||||||||||
| share issue | |||||||||||||||
| interest | -172 | -47 | |||||||||||||
| cash flow from financing | -172 | -47 | |||||||||||||
| cash and cash equivalents | |||||||||||||||
| cash | -34,682 | -8,274 | 157,093 | 20,827 | 610,172 | -593,652 | 136,682 | 26,212 | -128,699 | 323,067 | 228,861 | -39,259 | -3,260 | 50,048 | |
| overdraft | |||||||||||||||
| change in cash | -34,682 | -8,274 | 157,093 | 20,827 | 610,172 | -593,652 | 136,682 | 26,212 | -128,699 | 323,067 | 228,861 | -39,259 | -3,260 | 50,048 |
beanibazar cancer and general hospital Credit Report and Business Information
Beanibazar Cancer And General Hospital Competitor Analysis
Perform a competitor analysis for beanibazar cancer and general hospital by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other micro companies, companies in SE1 area or any other competitors across 12 key performance metrics.
beanibazar cancer and general hospital Ownership
BEANIBAZAR CANCER AND GENERAL HOSPITAL group structure
Beanibazar Cancer And General Hospital has no subsidiary companies.
Ultimate parent company
BEANIBAZAR CANCER AND GENERAL HOSPITAL
06882020
beanibazar cancer and general hospital directors
Beanibazar Cancer And General Hospital currently has 5 directors. The longest serving directors include Mr Mohammad Uddin (Apr 2009) and Mr Mohammed Uddin (Mar 2016).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Mohammad Uddin | 63 years | Apr 2009 | - | Director | |
| Mr Mohammed Uddin | United Kingdom | 51 years | Mar 2016 | - | Director |
| Shams Khan | England | 89 years | Mar 2016 | - | Director |
| Mr Shalim Uddin | United Kingdom | 49 years | Mar 2016 | - | Director |
| Mr Shalim Uddin | United Kingdom | 49 years | Mar 2016 | - | Director |
P&L
March 2024turnover
298.6k
+33%
operating profit
-48.8k
0%
gross margin
34.4%
+3.12%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
March 2024net assets
1.3m
-0.01%
total assets
1.3m
-0.01%
cash
745.1k
-0.04%
net assets
Total assets minus all liabilities
Similar Companies
beanibazar cancer and general hospital company details
company number
06882020
Type
Private Limited by guarantee without Share Capital Exempt from using Limited
industry
86101 - Hospital activities
incorporation date
April 2009
age
16
incorporated
UK
ultimate parent company
accounts
Total Exemption Full
last accounts submitted
March 2024
previous names
beanibazar cancer and general hospital limited (July 2019)
the beani bazar cancer hospital (July 2019)
accountant
MONZUR SUMON
auditor
-
address
74-76 tower bridge road, london, SE1 4TP
Bank
-
Legal Advisor
-
beanibazar cancer and general hospital Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to beanibazar cancer and general hospital.
beanibazar cancer and general hospital Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for BEANIBAZAR CANCER AND GENERAL HOSPITAL. This can take several minutes, an email will notify you when this has completed.
beanibazar cancer and general hospital Companies House Filings - See Documents
| date | description | view/download |
|---|
